With more than 25 years of experience as a senior advisor at FDA, Sharon Mayl advises clients in the areas of in the areas of food and ingredient safety, imports, third-party audits, nutrition labelling, dietary supplements, infant formula, and cannabis products. She applies her insider experience to help clients navigate the black box of FDA, finding strategic and practical solutions to complex regulatory and compliance problems.
Sharon provides strategic advice and regulatory counsel to clients in a variety of areas, including the FDA Food Safety Modernization Act (FSMA), ingredient and product development, supplier verification, nutrition labelling and claims, infant formula development, and dietary supplements, she also advises cosmetics clients on compliance with the Modernization of Cosmetics Regulation Act (MoCRA), labelling and safety issues. Sharon uses her decades of experience at the agency to assist clients with FDA interactions and meetings, including with respect to policy development and compliance actions such as warning letters and inspection reports.
During her time as a senior advisor in the Commissioner’s Office, Sharon advised several deputy commissioners on a wide range of regulatory, legislative and policy issues. Sharon played a leading role in implementing FSMA and developing strategic approaches to imports, the Nutrition Labelling and Education Act, cannabis policy. She regularly represented the agency in meetings with senior administration officials, Congress, federal and state regulatory agencies, foreign governments, industry representatives and consumer and public health groups. In these cross-organizational efforts, she established herself as a top government official in her space and forged close and cooperative relationships to achieve solutions to novel, controversial and complex issues. Sharon has received numerous awards and distinctions for her public service, including the Commissioner’s Award of Excellence for her outstanding contributions to food safety and imports.